Welcome to TRON

TRON – Translational Oncology at the University Medical Center of the Johannes Gutenberg University Mainz is a biopharmaceutical research organization that pursues new diagnostics and drugs for the treatment of cancer and other severe diseases with high medical need. A focus of TRON is the development of novel platforms for individualized therapies and biomarkers, translating basic research into drug applications. TRON partners with academic institutions, biotech companies and the pharmaceutical industry, executing research with leading-edge technologies and supporting the development of innovative drugs to promote human health.

The promising results show that personalised cancer vaccines designed to treat skin cancer are safe to use, and that for some patients, they can successfully harness the power of the body’s own immune system to kill cancer cells.

Dr Catherine Pickworth, Science Communication Officer at Cancer Research UK See article

This study in mice provides the first evidence that we may be on the threshold of being able to produce individualised vaccines directed against specific mutations present in a patient’s tumour. Rapid production of purpose-built vaccines appears to be possible and can now be tested in carefully designed clinical trials. As yet, this approach must be seen as experimental but it potentially represents a new way of harnessing the power of the immune system against cancer.

Prof. Kevin Harrington, Institute of Cancer Research, London See article

If these personalized cancer vaccines do prove to be effective and safe in patients, it could be the first step in saving millions of lives.

fusion.net See article